Our companies

A portfolio of innovation
Accelerating progress in life sciences

COMPASS Pathways

develops psilocybin therapy for patients with treatment-resistant depression.
compasspathways.com

Perception Neuroscience

develops arketamine therapy for patients with neuropsychiatric diseases.
perceptionneuroscience.com

Innoplexus

leverages the power of AI and big data analytics for a variety of applications in life sciences, like drug development.
innoplexus.com

GABA Therapeutics

develops GRX-917 — a deuterated version of etifoxine — for anxiety.
gabarx.com